Physician profile
Susan Hyde
NPI 1710476635
$2,965.90
in general payments reported to CMS, 2019-2025
37 companies · $16.20 in 2025
The $16.20 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,778 · 2022: $933 · 2023: $112 · 2024: $127 · 2025: $16.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $291.14 | 2021-2022 | |
| Lilly USA, LLC | $284.39 | 2021-2022 | |
| Insulet Corporation | $231.47 | 2021-2023 | Omnipod |
| Dexcom, INC. | $221.33 | 2021-2023 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $155.75 | 2021-2022 | |
| Zealand Pharma US, INC. | $128.44 | 2021 | |
| Esperion Therapeutics, INC. | $127.64 | 2021-2022 | |
| Ethicon US, LLC | $127.14 | 2024 | Stratafix, Monocryl |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.85 | 2021-2022 | |
| Corcept Therapeutics | $114.65 | 2021-2022 | |
| Amgen INC. | $114.25 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $97.03 | 2021-2022 | |
| Radius Health, INC. | $83.13 | 2021 | |
| Abbvie INC. | $82.77 | 2021 | |
| Amarin Pharma, INC. | $66.35 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifescan, INC. | $62.21 | 2022 | |
| Vivus LLC | $57.08 | 2021 | |
| Ibsa Pharma INC. | $56.87 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $55.38 | 2021-2023 | Gvoke Hypopen |
| Antares Pharma, INC. | $55.07 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $52.46 | 2021-2022 | |
| Abbott Laboratories | $47.17 | 2022 | |
| Currax Pharmaceuticals LLC | $38.93 | 2021 | |
| Merck Sharp & Dohme LLC | $37.97 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.13 | 2021 | |
| Boston Scientific Corporation | $24.09 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $22.12 | 2022 | |
| Mannkind Corporation | $20.12 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.08 | 2022 | |
| Pfizer INC. | $18.14 | 2021 | |
| Horizon Therapeutics Plc | $17.64 | 2021 | |
| Grt US Holding, INC. | $17.48 | 2022 | |
| Recordati_rare_diseases_inc. | $16.94 | 2021 | |
| Medtronic, INC. | $16.94 | 2021 | |
| Phadia US INC. | $16.37 | 2021 | |
| Haemonetics Corporation | $16.20 | 2025 | Teg5000 Hemostasis Analyzer |
| Novartis Pharmaceuticals Corporation | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Hyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.